Detalles de la búsqueda
1.
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association.
Circulation;
148(20): 1636-1664, 2023 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37807920
2.
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.
Circulation;
148(20): 1606-1635, 2023 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37807924
3.
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.
N Engl J Med;
384(17): 1601-1612, 2021 04 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-33913638
4.
Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.
N Engl J Med;
384(17): 1589-1600, 2021 04 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-33913637
5.
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
N Engl J Med;
385(20): 1845-1855, 2021 11 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34758252
6.
Meta-analysis of risk of major adverse cardiovascular events in adults with type 2 diabetes treated with bexagliflozin.
Diabetes Obes Metab;
26(3): 971-979, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38151752
7.
Elucidating the Clinical Implications and Pathophysiology of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Call to Action: A Science Advisory From the American Heart Association.
Circulation;
146(7): e73-e88, 2022 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35862198
8.
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial.
Circulation;
146(23): 1749-1757, 2022 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36321459
9.
The trial to assess chelation therapy 2 (TACT2): Rationale and design.
Am Heart J;
252: 1-11, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35598636
10.
Prognostic Impact of Cardiovascular Versus Noncardiovascular Hospitalizations in Heart Failure With Preserved Ejection Fraction: Insights From TOPCAT.
J Card Fail;
28(9): 1390-1397, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35636727
11.
Health System-Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: Results From the CONNECT-HF Trial.
J Card Fail;
28(8): 1355-1361, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35462033
12.
Catheter Ablation for Atrial Fibrillation in Heart Failure - An Option to Defer Transplantation?
N Engl J Med;
389(15): 1429-1430, 2023 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37819960
13.
Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics.
Am Heart J;
235: 1-11, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33129989
14.
Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical Trial.
JAMA;
326(4): 314-323, 2021 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34313687
15.
Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF.
Circulation;
140(17): 1369-1379, 2019 10 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31510768
16.
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure: Rationale and design of CONNECT-HF.
Am Heart J;
220: 41-50, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31770656
17.
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association.
Circulation;
137(20): e578-e622, 2018 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29650544
18.
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.
Circulation;
137(9): 961-972, 2018 02 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29483172
19.
Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Am J Kidney Dis;
73(3): 309-315, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30578152
20.
Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease.
Diabetes Obes Metab;
21(5): 1199-1208, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30672083